OS Therapies Archives - intelligence360

OS Therapies Announces Closing of $6 Million Private Placement

January 7, 2025 Craig Etkin

December 31, 2024 03:38 PM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or the “Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced the closing of a…

OS Therapies has filed a notice of an exempt offering of securities to raise $2,000,000.00 in Equity Investment.

January 23, 2023 Craig Etkin

Rockville, MD – According to filings with the U.S. Securities and Exchange Commission, OS Therapies is raising $2,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Paul Romness played a…

intelligence360

The Intelligent News Source

Tag: OS Therapies

OS Therapies Announces Closing of $6 Million Private Placement

January 7, 2025 Craig Etkin

OS Therapies has filed a notice of an exempt offering of securities to raise $2,000,000.00 in Equity Investment.

January 23, 2023 Craig Etkin